Gallinée was founded in 2014 by Marie Drago, PharmD, a world recognized specialist in skin microbiome.
Together with Prof. Ted Dinan (UCC Ireland), in this episode we discuss the link between gut, insomnia and anxiety.
Even though probiotics market is expanding worldwide, EU consumers cannot be informed about the presence of probiotics in food and food supplements.
Sam Costello (The Queen Elizabeth Hospital in Adelaide) presented recent evidences about FMT and IBDs.
COVID-19 alters the local immunity of the lung in ways that weaken the body’s antimicrobial defense and facilitate the development of secondary infections.
The findings of a recent study suggest that phages can be used to treat IBD and other diseases associated with gut microbes.
RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrence of C. difficile infection after antibiotic treatment
The Italian-based leader in the European nutraceutical CDMO market announces the acquisition of Nutraskills, a French company specialized in the research and development, production, and packaging of food supplements for…
Ghaith Bakdash described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.
The findings of a recent study suggest that engineered native gut bacteria could be employed to help treat certain diseases such as diabetes.
